Cargando…
Impact of Autologous Stem Cell Transplantation on Primary Central Nervous System Lymphoma in First-Line and Relapse Settings: A Retrospective Study in China
BACKGROUND: Myeloablative chemotherapy supported by autologous stem cell transplantation (ASCT) is an option for primary central nervous system lymphoma (PCNSL) in both the relapse setting and as postremission consolidation, but the level of evidence in this field is still low. MATERIAL/METHODS: We...
Autores principales: | Liu, Jing, Wang, Haitao, Li, Xiaohong, Wu, Yamei, Ma, Yuanyuan, Gu, Zhenyang, Li, Fei, Li, Meng, Guo, Jiayuan, Zhao, Yu, Wang, Quanshun, Bo, Jian, Huang, Wenrong, Dou, Liping, Liu, Yuanbo, Liu, Daihong, Wu, Xiaoxiong, Gao, Chunji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825020/ https://www.ncbi.nlm.nih.gov/pubmed/36593744 http://dx.doi.org/10.12659/AOT.938467 |
Ejemplares similares
-
T Cell-Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation for Treatment of T-Lymphoblastic Lymphoma
por: Guan, Lixun, et al.
Publicado: (2018) -
Efficacy and Safety of Autologous Stem-Cell Transplantation as Part of First-Line Treatment for Newly Diagnosed Primary Central Nervous System Lymphoma: A Systematic Review and Meta-Analysis
por: Liu, Jing, et al.
Publicado: (2022) -
Myeloablative Haploidentical Transplant as an Alternative to Matched Sibling Transplant for Peripheral T-Cell Lymphomas
por: Zhenyang, Gu, et al.
Publicado: (2021) -
Reduced risk of chronic GVHD by low-dose rATG in adult matched sibling donor peripheral blood stem cell transplantation for hematologic malignancies
por: Dou, Liping, et al.
Publicado: (2019) -
Haematologic malignancies with unfavourable gene mutations benefit from donor lymphocyte infusion with/without decitabine for prophylaxis of relapse after allogeneic HSCT: A pilot study
por: Zhang, Rui, et al.
Publicado: (2021)